Palombella Vito J. 4
4 · Surface Oncology, Inc. · Filed Mar 4, 2019
Insider Transaction Report
Form 4
Palombella Vito J.
Chief Scientific Officer
Transactions
- Award
Stock Option (Right to Buy)
2019-03-01+90,000→ 90,000 totalExercise: $4.27Exp: 2029-03-01→ Common Stock (90,000 underlying)
Footnotes (1)
- [F1]The stock option vests and becomes exercisable in 48 equal monthly installments after February 12, 2019.